[Transdermal system].
D000279:Administration, Cutaneous; D004334:Drug Administration Schedule; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000188:drug therapy / Q000451:nursing*
D008333:Mandelic Acids; C005419:oxybutynin